Literature DB >> 15723268

Rapid development of glomerular injury and renal failure in mice lacking p53R2.

David R Powell1, Urvi Desai, Mary Jean Sparks, Gwenn Hansen, Jason Gay, Jeff Schrick, Zheng-Zheng Shi, John Hicks, Peter Vogel.   

Abstract

The Rrm2b gene encodes p53R2, a catalytic subunit of ribonucleotide reductase that is required for DNA repair. Embryonic stem (ES) cells containing a retroviral insertion in the Rrm2b locus were used to generate mutant mice. Analysis of kidney RNA from Rrm2b (-/-) mice showed that the retroviral insertion disrupted expression of Rrm2b transcripts. Rrm2b (-/-) pups were represented at the expected Mendelian ratios at 10-12 days of age and grew normally past weaning. Mice failed to thrive after 6 weeks of age and began to die by 8 weeks of age. Phenotyping revealed that Rrm2b (-/-) mice died from a severe glomerular lesion that led to nephrotic syndrome and chronic renal failure. In kidneys of Rrm2b (-/-) mice, podocytes were enlarged and there was evidence of foot process effacement by 6 weeks of age. By 8 weeks of age, progressive podocyte hypertrophy and loss of foot processes was accompanied by hypertrophy of glomerular capillary endothelial cells that was extensive enough to restrict capillary blood flow. Collapsing glomerulopathy with avascular glomeruli was widespread in mice surviving beyond 9 weeks of age. Additional abnormalities in other organ systems were minor or consistent with secondary effects of renal failure. These findings suggest that lack of p53R2, the protein encoded by Rrm2b, has early and relatively selective detrimental effects on the kidney glomerulus that lead to rapid death from progressive renal failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723268     DOI: 10.1007/s00467-004-1696-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  28 in total

Review 1.  Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm.

Authors:  K Tryggvason
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

Review 2.  In vivo drug target discovery: identifying the best targets from the genome.

Authors:  D W Walke; C Han; J Shaw; E Wann; B Zambrowicz; A Sands
Journal:  Curr Opin Biotechnol       Date:  2001-12       Impact factor: 9.740

Review 3.  Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industry.

Authors:  Brian P Zambrowicz; C Alexander Turner; Arthur T Sands
Journal:  Curr Opin Pharmacol       Date:  2003-10       Impact factor: 5.547

4.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

Authors:  J M Kaplan; S H Kim; K N North; H Rennke; L A Correia; H Q Tong; B J Mathis; J C Rodríguez-Pérez; P G Allen; A H Beggs; M R Pollak
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

5.  Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells.

Authors:  B P Zambrowicz; G A Friedrich; E C Buxton; S L Lilleberg; C Person; A T Sands
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

6.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.

Authors:  N Boute; O Gribouval; S Roselli; F Benessy; H Lee; A Fuchshuber; K Dahan; M C Gubler; P Niaudet; C Antignac
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

7.  Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN.

Authors:  D B Donoviel; D D Freed; H Vogel; D G Potter; E Hawkins; J P Barrish; B N Mathur; C A Turner; R Geske; C A Montgomery; M Starbuck; M Brandt; A Gupta; R Ramirez-Solis; B P Zambrowicz; D R Powell
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

8.  Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis.

Authors:  Frank C Tinsley; Gersh Z Taicher; Mark L Heiman
Journal:  Obes Res       Date:  2004-01

9.  Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.

Authors:  Brian P Zambrowicz; Alejandro Abuin; Ramiro Ramirez-Solis; Lizabeth J Richter; James Piggott; Hector BeltrandelRio; Eric C Buxton; Joel Edwards; Rick A Finch; Carl J Friddle; Anupma Gupta; Gwenn Hansen; Yi Hu; Wenhu Huang; Crystal Jaing; Billie Wayne Key; Peter Kipp; Buckley Kohlhauff; Zhi-Qing Ma; Diane Markesich; Robert Payne; David G Potter; Ny Qian; Joseph Shaw; Jeff Schrick; Zheng-Zheng Shi; Mary Jean Sparks; Isaac Van Sligtenhorst; Peter Vogel; Wade Walke; Nianhua Xu; Qichao Zhu; Christophe Person; Arthur T Sands
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

Review 10.  Glomerular protein trafficking and progression of renal disease to terminal uremia.

Authors:  A Benigni; G Remuzzi
Journal:  Semin Nephrol       Date:  1996-05       Impact factor: 5.299

View more
  13 in total

1.  Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function.

Authors:  David P Harris; Peter Vogel; Marie Wims; Karen Moberg; Juliane Humphries; Kanchan G Jhaver; Christopher M DaCosta; Melanie K Shadoan; Nianhua Xu; Gwenn M Hansen; Sanjeevi Balakrishnan; Jan Domin; David R Powell; Tamas Oravecz
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

2.  Structural basis on the dityrosyl-diiron radical cluster and the functional differences of human ribonucleotide reductase small subunits hp53R2 and hRRM2.

Authors:  Bingsen Zhou; Leila Su; Yate-Ching Yuan; Frank Un; Norby Wang; Madhukar Patel; Bixin Xi; Shuya Hu; Yun Yen
Journal:  Mol Cancer Ther       Date:  2010-05-18       Impact factor: 6.261

3.  The kd/kd mouse is a model of collapsing glomerulopathy.

Authors:  Laura Barisoni; Michael P Madaio; Maria Eraso; David L Gasser; Peter J Nelson
Journal:  J Am Soc Nephrol       Date:  2005-08-24       Impact factor: 10.121

4.  Telomerase at the center of collapsing glomerulopathy.

Authors:  Sumant S Chugh; Lionel C Clement
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

5.  Large-scale gene trapping in C57BL/6N mouse embryonic stem cells.

Authors:  Gwenn M Hansen; Diane C Markesich; Michael B Burnett; Qichao Zhu; Karen M Dionne; Lizabeth J Richter; Richard H Finnell; Arthur T Sands; Brian P Zambrowicz; Alejandro Abuin
Journal:  Genome Res       Date:  2008-09-17       Impact factor: 9.043

6.  Chromosomal instability triggered by Rrm2b loss leads to IL-6 secretion and plasmacytic neoplasms.

Authors:  Lufen Chang; Robin Guo; Qin Huang; Yun Yen
Journal:  Cell Rep       Date:  2013-05-02       Impact factor: 9.423

7.  Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice.

Authors:  Urvi Desai; E-Chiang Lee; Kyu Chung; Cuihua Gao; Jason Gay; Billie Key; Gwenn Hansen; Dennis Machajewski; Kenneth A Platt; Arthur T Sands; Matthias Schneider; Isaac Van Sligtenhorst; Adisak Suwanichkul; Peter Vogel; Nat Wilganowski; June Wingert; Brian P Zambrowicz; Greg Landes; David R Powell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

8.  Characterization of PTPRG in knockdown and phosphatase-inactive mutant mice and substrate trapping analysis of PTPRG in mammalian cells.

Authors:  Wandong Zhang; Katerina V Savelieva; David T Tran; Vladimir M Pogorelov; Emily B Cullinan; Kevin B Baker; Kenneth A Platt; Sean Hu; Indrani Rajan; Nianhua Xu; Thomas H Lanthorn
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

9.  Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase.

Authors:  Giovanna Pontarin; Paola Ferraro; Chiara Rampazzo; Gittan Kollberg; Elisabeth Holme; Peter Reichard; Vera Bianchi
Journal:  J Biol Chem       Date:  2011-02-05       Impact factor: 5.157

10.  RRM2B suppresses activation of the oxidative stress pathway and is up-regulated by p53 during senescence.

Authors:  Mei-Ling Kuo; Alexander J Sy; Lijun Xue; Martin Chi; Michelle T-C Lee; Terence Yen; Mei-Iok Chiang; Lufen Chang; Peiguo Chu; Yun Yen
Journal:  Sci Rep       Date:  2012-11-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.